Evidence map›Paper›PMID 41945138›Full record

ArticleNaunyn-Schmiedeberg's archives of pharmacology2026

Synthesis and characterization of NiTiO₃-L-ornithine nanoparticles and their antibacterial, antifungal, antioxidant activities, and zebrafish biocompatibility.

Manabendra Sandilya, Pratap Kumar Sahu, Mahaboob Pasha, Menka Bhasin, Indumathi Thangavelu, Srinivas Tadepalli, Ahmed A Bhran

Abstract read
PubMed Publisher
In one paragraph

Article in Naunyn-Schmiedeberg's archives of pharmacology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Manabendra SandilyaDepartment of Biomedical Engineering, Faculty of Engineering and Technology, Parul Institute of Technology, Parul University, Vadodara, 391760, Gujarat, India.
Pratap Kumar SahuDepartment of Pharmaceutical Sciences, School of Pharmaceutical Sciences, Siksha 'O' Anusandhan (Deemed to Be University), Bhubaneswar, 751030, Odisha, India.
Mahaboob PashaDepartment of Physics, Presidency University, Bengaluru, 560064, Karnataka, India.
Menka BhasinDepartment of FBAS (Chemistry), Vivekananda Global University, Jaipur, 303012, India.
Indumathi ThangaveluDepartment of Chemistry, CHRIST (Deemed to Be University), Bangalore, Karnataka, 560029, India.
Srinivas TadepalliDepartment of Chemical Engineering, College of Engineering, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, 11432, Kingdom of Saudi Arabia. stadepalli@imamu.edu.sa.
Ahmed A BhranDepartment of Chemical Engineering, College of Engineering, Imam Mohammad Ibn Saud Islamic University (IMSIU), Riyadh, 11432, Kingdom of Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The increasing prevalence of antimicrobial resistance and biofilm-associated infections demands multifunctional nanomaterials with improved efficacy and safety. In this study, defect-engineered nickel titanate (NiTiO₃) nanoparticles functionalized with L-Ornithine (NiTiO₃-LO) were synthesized via a co-precipitation approach to enhance antimicrobial performance while maintaining biocompatibility. XRD analysis confirmed phase-pure rhombohedral NiTiO₃ with reduced crystallite size upon functionalization (31.3 ± 2 nm to 26.2 ± 2 nm). XPS and FTIR analyses verified successful LO surface coordination and modulation of oxygen vacancy-related defect states. PL studies revealed defect-mediated green emissions (507-529 nm), indicating stabilized oxygen vacancies after functionalization. NiTiO₃-LO exhibited significantly enhanced antibacterial and antifungal activity, with inhibition zones of 17.9 ± 0.4 mm and 18.9 ± 0.4 mm, respectively. The nanoparticles also demonstrated concentration-dependent antioxidant activity, achieving ~ 63% DPPH scavenging at 100 µg/mL, comparable to Vitamin C (~ 65%). Importantly, zebrafish embryo assays showed no observable developmental toxicity, indicating favourable in vivo biocompatibility. These findings establish NiTiO₃-LO as a defect-modulated, multifunctional nanoplatform integrating antimicrobial, antioxidant, and biocompatible properties for potential biomedical applications.

Indexed as

Anti-Bacterial AgentsAntifungal AgentsAntioxidantsMetal NanoparticlesNanoparticlesNickelTitaniumAnimalsMicrobial Sensitivity TestsZebrafishAnti-Bacterial AgentsAntifungal AgentsAntioxidantsNickelTitaniumAntimicrobial activityAntioxidantBiocompatibilityLONiTiO3

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.